Get the Stockscreener App
0.90
0.72%
0.0071
Hyperfine Inc stock is traded at $0.90, with a volume of 766.73K.
It is up +0.72% in the last 24 hours and down -3.37% over the past month.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.
See More
Previous Close:
$0.8929
Open:
$0.91
24h Volume:
766.73K
Relative Volume:
0.79
Market Cap:
$95.44M
Revenue:
$15.33M
Net Income/Loss:
$-34.78M
P/E Ratio:
-2.2021
EPS:
-0.4087
Net Cash Flow:
$-28.66M
1W Performance:
-5.33%
1M Performance:
-3.37%
6M Performance:
-18.24%
1Y Performance:
-35.30%
1-Day Range:
$0.8826
$0.9288
1-Week Range:
$0.88
$0.99
52-Week Range:
$0.85
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
Name
Hyperfine Inc
Sector
Industry
Phone
866-796-6767
Address
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
0.90 | 94.69M | 15.33M | -34.78M | -28.66M | -0.4087 |
ABT
Abbott Laboratories
|
110.23 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.55 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.62 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.56 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.86 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-31-22 | Initiated | Evercore ISI | Outperform |
| Apr-14-22 | Initiated | Wells Fargo | Overweight |
Hyperfine Inc Stock (HYPR) Latest News
Hyperfine (HYPR) Q2 2026 Earnings Call Transcript - AOL.com
Hyperfine, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-08-10 - Seeking Alpha
HYPR Reiterates by B. Riley Securities -- Price Target Lowers to $1.60 - GuruFocus
B. Riley Financial Reaffirms Buy Rating for Hyperfine (NASDAQ:HYPR) - MarketBeat
Hyperfine Q2 2026 slides: 45% revenue growth, AI-powered MRI expansion - Investing.com Australia
Hyperfine Inc (HYPR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Hyperfine Touts Positive Results From Portable MRI Study - Medical Product Outsourcing
Hyperfine, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Hyperfine (NASDAQ:HYPR) Announces Quarterly Earnings Results - MarketBeat
Hyperfine Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates - Investing.com
Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Hyperfine : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.com
Hyperfine (HYPR) Releases Q2 2026 Earnings: Revenue Growth but EPS in Line - Quiver Quantitative
Hyperfine Q2 2026 earnings: Revenue rises 45% as operating loss narrows - TradingKey
Hyperfine, Inc. Q2 2026: Revenue $3.904M, EPS $(0.09) — 10-Q Summary - TradingView
Portable MRI maker Hyperfine's Q2 revenue rises less than expected - TradingView
Hyperfine, Inc. (HYPR) Q2 FY2026 earnings call transcript - Yahoo Finance
Hyperfine reports Q2 2026 revenue $3.9M, net loss $9.3M, expands international approvals - TradingView
Hyperfine, Inc. (NASDAQ: HYPR) grows Q2 sales but remains unprofitable - Stock Titan
Hyperfine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Hyperfine (Nasdaq: HYPR) grows Q2 2026 revenue 44.8% as cash rises to $43.5M - Stock Titan
HYPR: Q2 2026 delivered robust revenue growth, margin expansion, and accelerated global adoption - TradingView
BRIEF-Hyperfine, Inc. Q2 EPS USD -0.09 - TradingView
Hyperfine, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Earnings To Watch: Hyperfine Inc (HYPR) Q2 2026 -- GF Value Sees 72% Upside - Yahoo Finance
Hyperfine Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Hyperfine, Inc. Revenue Breakdown – NASDAQ:HYPR - TradingView
Hyperfine’s portable MRI system featured in medical journals By Investing.com - Investing.com Canada
Hyperfine Inc. (HYPR) Q1 2026 Earnings: Narrower Loss Beats Estimates, Shares SlideEarnings Trend Analysis - dars.gov.et
New Hyperfine Swoop® Portable MRI for Easier and Faster Stroke Visualization - marketscreener.com
HYPR|Hyperfine Inc|Price:0.936|Chg%:+0.008 - TradingKey
Hyperfine Inc (HYPR) Institutional Confidence - TradingKey
Hyperfine Inc (HYPR) Balance Sheet - TradingKey
HYPR|Hyperfine Inc|Price:0.970|Chg%:+0.016 - TradingKey
Hyperfine Inc (HYPR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Hyperfine Inc (HYPR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Hyperfine Inc (HYPR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hyperfine, Inc. (NASDAQ:HYPR) Receives Average Rating of "Hold" from Analysts - MarketBeat
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026 - Yahoo Finance
New Yale Study Shows Portable MRI Cuts Time to Brain Imaging by 80% in the Emergency Department - marketscreener.com
India Begins Using Hyperfine Swoop System for Bedside Brain Imaging - Medical Product Outsourcing
Peer-Reviewed Study Demonstrate Significant Economic and Operational Benefits of Portable MRI in Acute Hospital Care - marketscreener.com
Peer-Reviewte Studie belegt erhebliche wirtschaftliche und betriebliche Vorteile der mobilen MRT in Akutkrankenhäusern - Cision News
Enterprise value to EBITDA forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Price to earnings forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Enterprise value to EBIT forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Price to book forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Hyperfine Inc. (HYPR) Slides 4.89% as Stock Tests Key Support LevelsLow Beta Factor - dars.gov.et
Price to sales forward of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Hyperfine launches next-generation Swoop MRI system in Europe - Yahoo Finance
Hyperfine Inc Stock (HYPR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hyperfine Inc Stock (HYPR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| TEISSEYRE THOMAS | Chief Operating Officer |
May 26 '26 |
Sale |
1.65 |
6,047 |
9,978 |
678,601 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
354,648 |
| HALE BRETT | CFO and CAO |
Mar 23 '26 |
Sale |
1.21 |
24,188 |
29,267 |
275,812 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 13 '26 |
Sale |
1.11 |
821 |
913 |
378,836 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Nov 19 '25 |
Sale |
1.08 |
1,405 |
1,517 |
379,657 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 18 '25 |
Sale |
1.33 |
1,151 |
1,531 |
381,062 |
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):